Paulo Francisco Ramos Margarido

Paulo Francisco Ramos Margarido

Auto-generated profile, based on publicly available information

Paulo Francisco Ramos Margarido

Hospital Universitário Universidade de São Paulo São Paulo SP Brasil Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
VBVenina Isabel Poço Viana Leme de Barros
Venina Isabel Poço Viana Leme de Barros
AOAndré Luiz Malavasi Longo de Oliveira
André Luiz Malavasi Longo de Oliveira
DNDenis Jose Do Nascimento
Denis Jose Do Nascimento
EZEduardo Zlotnik
Eduardo Zlotnik
MTMarcelo Melzer Teruchkin
Marcelo Melzer Teruchkin
PMPaulo Francisco Ramos Margarido
Paulo Francisco Ramos Margarido
Key points •The risk of venous thromboembolism (VTE) is not increased in women using long-acting reversible contraceptive methods (LARCs) with progestogens. •Oral contraceptives with levonorgestrel or norgestimate confer half the risk of VTE compared to oral contraceptives containing desogestrel, gestodene or drospirenone. •Progestogen-only pills do not confer an increased risk of VTE. •Women using transdermal […] Key points •The risk of venous thromboembolism (VTE) is not increased in women using long-acting reversible contraceptive methods (LARCs) with progestogens. •Oral contraceptives with levonorgestrel or norgestimate confer half the risk of VTE compared to oral contraceptives containing desogestrel, gestodene or drospirenone. •Progestogen-only pills do not confer an increased risk of VTE. •Women using transdermal […]

25 August 2021 in Revista de Patologia Tropical / Journal of Tropical Pathology
Verified
Journal Article
Open access
PDF file
ASAna Clara De Souza
Ana Clara De Souza
CPClaudete Rodrigues Paula
Claudete Rodrigues Paula
LRLuciana Silva Ruiz
Luciana Silva Ruiz
PMPaulo Francisco Ramos Margarido
Paulo Francisco Ramos Margarido
MAMarcos Ereno Auler
Marcos Ereno Auler
CDCarina Domaneschi
Carina Domaneschi
This study characterized and related yeasts of the genus Candida isolated from vaginal mucous membranes of women with lesions caused by high-risk HPV for cervical cancer. Forty-two women treated at the Lower Genital Tract Pathology Clinic of the University of São Paulo Medical School Hospital of Clinics were examined, with 30 high-grade (G1) uterine lesions with a mean age of 36.5 years ± 11. 1 and 12 with low grade (G2) uterine lesions with a mean age of 34.7 years ± 15.5. Clinical conditions and laboratory data on HPV were collected from patients’ medical records; the socio-demographic data obtained from an appropriate questionnaire. For the study of association between the variables, Odds Ratio analysis was used from the STATA 13.1 program. Patients G1 had a higher prevalence for diabetes and the results indicated 27% prevalence of Candida spp. in vaginal mucosa, in G2 this was 33% in vaginal mucosa. Among the species found in vaginal mucosa of patients, Candida albicans was the most isolated with 88%, followed by C. tropicalis (8%) and C. glabrata (4%). The strains of C. albicans isolated from mucosa presented sensitivity to all antifungal agents tested, unlike the C. tropicalis strain isolated in G2 in vaginal mucosa, which presented a resistance profile to fluconazole. Thus, monitoring and supervision through clinical and laboratory testing of HPV patients is important, reinforcing the need for care, treatment and prevention of HPV-related infections and Candida spp. KEY WORDS: vaginal mucosa; uterine cervical neoplasms; human Papillomavirus; Candida spp. Antifungal sensitivity.